Transdermal delivery of levosimendan

被引:21
|
作者
Valjakka-Koskela, R
Hirvonen, J
Mönkkönen, J
Kiesvaara, J
Antila, S
Lehtonen, L
Urtti, A
机构
[1] Orion Corp Orion Pharma, Pharmaceut Dev Dept, Kuopio 70701, Finland
[2] Univ Helsinki, Pharm Technol Div, FIN-00014 Helsinki, Finland
[3] Univ Kuopio, Dept Pharmaceut, FIN-70211 Kuopio, Finland
[4] Orion Corp Orion Pharma, Pharmaceut Dev Dept, Kuopio 20101, Finland
[5] Orion Corp Orion Pharma, Cardiovasc Project, Espoo 02101, Finland
[6] Univ Helsinki, Dept Clin Pharmacol, Huch 00290, Finland
关键词
levosimendan; transdermal delivery; iontophoresis; solubility; penetration enhancement;
D O I
10.1016/S0928-0987(00)00120-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this study was to determine if transdermal penetration of levosimendan, a novel positive inotropic drug, could be enhanced and controlled by formulation modifications. Penetration of levosimendan across human epidermis in vitro was determined using abdominal excised skin and diffusion cells. Predicted steady-state plasma concentrations of levosimendan were estimated using permeabilities and pharmacokinetic parameters of levosimendan. For penetration enhancement we used different pH values, co-solvents, cyclodextrins, surfactants, penetration enhancers, liposomes, and iontophoresis. Sodium lauryl sulfate, ethanol, oleic acid, and soya phosphatidylcholine or their combinations clearly increased levosimendan permeation across the skin in vitro. Iontophoresis was also an efficient method to increase transdermal permeation of levosimendan. A hydrophilic co-solvent/penetration enhancer is needed to achieve better permeability of levosimendan across the skin. In conclusion, transdermal delivery of levosimendan can be significantly increased by formulation modification. Based on kinetic calculations, therapeutic plasma concentrations may be achievable transdermally, (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:343 / 350
页数:8
相关论文
共 50 条
  • [1] Transdermal Delivery of Proteins
    Kalluri, Haripriya
    Banga, Ajay K.
    AAPS PHARMSCITECH, 2011, 12 (01): : 431 - 441
  • [2] Transdermal Delivery of Proteins
    Haripriya Kalluri
    Ajay K. Banga
    AAPS PharmSciTech, 2011, 12 : 431 - 441
  • [3] Advances in transdermal insulin delivery
    Zhang, Yuqi
    Yu, Jicheng
    Kahkoska, Anna R.
    Wang, Jinqiang
    Buse, John B.
    Gu, Zhen
    ADVANCED DRUG DELIVERY REVIEWS, 2019, 139 : 51 - 70
  • [4] Microneedles and transdermal drug delivery
    Kalluri, H.
    Banga, A. K.
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2009, 19 (05) : 303 - 310
  • [5] Transdermal delivery of indomethacin by iontophoresis
    Kanebako, M
    Inagi, T
    Takayama, K
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2002, 25 (06) : 779 - 782
  • [6] Electrically enhanced transdermal delivery of domperidone
    Jadoul, A
    Preat, V
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 154 (02) : 229 - 234
  • [7] TRANSDERMAL DRUG DELIVERY AND METHODS TO ENHANCE IT
    Kuznetsova, E. G.
    Ryzhikova, V. A.
    Salomatina, L. A.
    Sevastianov, V. I.
    VESTNIK TRANSPLANTOLOGII I ISKUSSTVENNYH ORGANOV, 2016, 18 (02): : 152 - 162
  • [8] Studies on Transdermal Delivery Enhancement of Zidovudine
    Takmaz, Evrim Atilay
    Inal, Oezge
    Baykara, Tamer
    AAPS PHARMSCITECH, 2009, 10 (01): : 88 - 97
  • [9] Studies on Transdermal Delivery Enhancement of Zidovudine
    Evrim Atilay Takmaz
    Özge Inal
    Tamer Baykara
    AAPS PharmSciTech, 2009, 10 : 88 - 97
  • [10] Transdermal delivery of analgesics
    Hartrick, Craig T.
    THERAPEUTIC DELIVERY, 2011, 2 (05) : 541 - 544